Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Donegal (DGICA) Shares Outstanding (Weighted Average) (2016 - 2026)

Donegal has reported Shares Outstanding (Weighted Average) over the past 16 years, most recently at $30.7 million for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 451.26% to $30.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.7 million through Dec 2025, up 451.26% year-over-year, with the annual reading at $30.7 million for FY2025, 451.26% up from the prior year.
  • Shares Outstanding (Weighted Average) was $30.7 million for Q4 2025 at Donegal, down from $31.0 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $31.0 million in Q3 2025 and troughed at $5.6 million in Q3 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $5.6 million (2021), against an average of $15.5 million.
  • Year-over-year, Shares Outstanding (Weighted Average) plummeted 79.49% in 2024 and then skyrocketed 455.03% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $25.4 million in 2021, then grew by 4.02% to $26.4 million in 2022, then tumbled by 78.88% to $5.6 million in 2023, then changed by 0.0% to $5.6 million in 2024, then surged by 451.26% to $30.7 million in 2025.
  • Per Business Quant, the three most recent readings for DGICA's Shares Outstanding (Weighted Average) are $30.7 million (Q4 2025), $31.0 million (Q3 2025), and $30.7 million (Q2 2025).